DEA Says Cannabis Rescheduling Process Remains Pending Despite Trump Executive Order
Key Takeaway
The DEA confirmed that the marijuana rescheduling appeal process remains pending despite President Trump's December 2025 executive order directing expedited movement from Schedule I to Schedule III. The process had been sidelined since January 2025, complicated by the DEA administrative law judge retiring.
What This Means for Cannabis Businesses
Federal policy changes ripple across the entire cannabis industry. Whether it's rescheduling progress, banking legislation, or court rulings, these developments shape the operating environment for businesses in every legal state. Operators should monitor these developments closely and consult with their legal counsel to understand the implications for their specific markets and operations.
Related Guides
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
New Congressional Research Report on Cannabis Rescheduling Published
Federal Government Warns About Cannabis and Hemp in Drug Tests
House Agriculture Committee Advances Farm Bill Without Hemp THC Ban Delay
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.